Cited by 30Suicide and Self-Harm StudiesTreatment of Major DepressionBipolar Disorder and Treatment

Investigation of blood mRNA biomarkers for suicidality in an independent sample

Open access
Mullins, N, Hodgson, K, Tansey, K E, Perroud, N, Maier, W, Mors, O, Rietschel, M, Hauser, J +8 more·2014·Translational Psychiatry

Abstract

Changes in the blood expression levels of SAT1, PTEN, MAP3K3 and MARCKS genes have been reported as biomarkers of high versus low suicidality state (Le-Niculescu et al.). Here, we investigate these expression biomarkers in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study, of patients with major depressive disorder on a 12-week antidepressant treatment. Blood gene expression levels were available at baseline and week 8 for patients who experienced suicidal ideation during the study (n=20) versus those who did not (n=37). The analysis is well powered to detect the effect sizes reported in the original paper. Within either group, there was no significant change in the expression of these four genes over the course of the study, despite increasing suicidal ideation or initiation of antidepressant treatment. Comparison of the groups showed that the gene expression did not differ between patients with or without treatment-related suicidality. This independent study does not support the validity of the proposed biomarkers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/tp.2014.112

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mullins, N., Hodgson, K., Tansey, K. E., Perroud, N., Maier, W., Mors, O., Rietschel, M., Hauser, J., Henigsberg, N., Souery, D., Aitchison, K., Farmer, A., McGuffin, P., Breen, G., Uher, R., & Lewis, C. M.
Affiliations
  • King's College London (GB)
  • Cardiff University (GB)
  • University Hospital of Geneva (CH)
  • University of Bonn (DE)
  • Aarhus University Hospital (DK)
  • Poznan University of Medical Sciences (PL)
  • University of Zagreb (HR)
  • Université Libre de Bruxelles (BE)
  • University of Alberta (CA)
  • Dalhousie University (CA)
  • Guy's Hospital (GB)
Corresponding author
Mullins, N
Venue
Translational Psychiatry
Published
2014-10-28
Volume
4
Issue
10
Pages
e474-e474
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2061381094
Cited by
30
References
29
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2019: 4 · 2018: 16 · 2017: 3 · 2015: 2
FWCI
1.97
Type
journal article
Language
en
Open access
Locations
  • Translational Psychiatry (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (publishedVersion, other-oa)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
Funders
  • South London and Maudsley NHS Foundation Trust
  • Government of Alberta
  • National Institute for Health and Care Research
  • King's College London
  • European Commission (LSHB-CT-2003–503428, 503428, 286213, LSHB-CT-2003)
  • Canada Research Chairs
  • Lundbeckfonden (R155-2014-1724)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
suicidality, suicidal ideation, blood gene expression, mRNA biomarkers, SAT1, PTEN, MAP3K3, MARCKS, major depressive disorder, antidepressant treatment, biomarker validation
MeSH terms
Myristoylated Alanine-Rich C Kinase Substrate, Diamine N-Acetyltransferase, Acetyltransferases, Adult, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Female, Follow-Up Studies, Genetic Markers, Humans, Male, Membrane Proteins, Middle Aged, RNA, Messenger, Gene Expression, Intracellular Signaling Peptides and Proteins, MAP Kinase Kinase Kinase 3, PTEN Phosphohydrolase, Suicidal Ideation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review